Investors

Print Friendly

Q4 2014 BioLife Solutions, Inc. Earnings Conference Call

March 12, 2015 Biolife Solutions Q4 Conference Call
4:30 PM ET Listen to webcast

 

About BioLife Solutions:

BioLife Solutions develops, manufactures and markets hypothermic storage and cryopreservation solutions and precision thermal shipping products for cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services. The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs.

Stock Information

Stock symbol: BLFS

SEC Filings